the DISC1 RNAi rescue, all not significantly different, Figure 1e ), suggesting that the effect of DISC1 is to increase the fraction of mitochondria engaged in the mobile phase rather than providing alternative pathways for more rapid movement.
Two non-synonymous single-nucleotide polymorphism variants of DISC1, Ser704Cys and Leu607Phe, associate with schizophrenia, bipolar disorder and major depression and have been linked to differences in synaptic function and brain maturation. 1, [8] [9] [10] We used shRNAi knockdown of DISC1 combined with coexpression of DISC1 variants resistant to the shRNAi to replace endogenous DISC1 with these variants and address whether the diseaseassociated polymorphisms influence mitochondrial trafficking. In neurons expressing shRNAi to knock down DISC1, both the common variant (which encodes Leu607/Ser704) and the Cys704 variant could equally rescue mitochondrial trafficking, suggesting no difference in these variants in regulating mitochondrial transport. In contrast, compared with the DISC1 common variant, the Phe607 DISC1 variant was unable to correctly rescue mitochondrial movement in DISC1 RNAi-expressing cells (28.78±2.7% for DISC1 common variant rescue compared with 20.63 ± 2.5% for Phe607 rescue, P = 0.047; Figure 1f and g). These results suggest that correct mitochondrial trafficking in neurons expressing the DISC1 Phe607 variant is significantly impaired.
Here, we report a novel role for DISC1 in regulating the axonal transport of mitochondria and also show that the disease-associated Leu607Phe polymorphism disrupts this function. The ability of DISC1 to regulate mitochondrial dynamics and associate with motor proteins suggests that it is part of an essential motor transport complex that directs mitochondrial trafficking in neurons. 1 Previous studies have revealed diverse effects of DISC1 on synaptogenesis, neurite outgrowth, neuronal migration and neurogenesis. 1 We propose that central to these effects is DISC1's role in the transport of mitochondria, an organelle whose correct function and dynamic localization is essential for neuronal development, communication and signaling. Thus, the regulation of mitochondrial transport and hence neuronal energy provision by DISC1 shown here represents a potentially exciting new target for investigation of underlying mechanisms of schizophrenia.
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The authors declare no conflict of interest. Dopamine plays a key role in the reward pathways within the brain. The plasma membrane dopamine transporter (DAT1) is found exclusively in dopamine neurones and regulates the reuptake of dopamine from the synapse. 1 A recently discovered polymorphism, allele 3 of the variable number tandem repeat in intron 8 (Int8 VNTR), has been linked with an increased propensity to abuse cocaine. 2 However, it is not clear how this allele influences the cortical substrate underlying reward processing. We describe the effects of a functional genetic variant in DAT1 on cortical activation during a functional magnetic resonance imaging study of reward processing in subjects treated with amphetamine.
Twenty subjects were randomized to receive either placebo or amphetamine while undergoing functional magnetic resonance imaging during a gambling task. DNA was extracted from whole blood using a modified phenol-chloroform procedure and genotyping conducted as described in Figure 1 . Eleven subjects possessed the at risk allele (allele 3 Int8 VNTR); of these, six received amphetamine and five received placebo. Of the nine subjects possessing the lower risk allele, five received amphetamine and four were given placebo.
All subjects were given d15 at the start of the experiment, and required to risk d1 on each subsequent gambling trial. Each trial consisted of a spinning roulette wheel, and the participants were cued to select one of two colours. The subjects total balance was updated with the win or losses.
Subjects underwent functional magnetic resonance imaging scanning approximately 120 min after the administration of either amphetamine or placebo. Imaging was performed with a 1.5T GE scanner (GE, WI, USA) with a single run of 270 volumes (matrix size 64 Â 64), with whole brain coverage, taking 18 min. Each volume comprised 43 slices, collected in an interleaved manner, with isometric 3 mm voxels and repetition time of 4 s (TE 40 ms Flip angle 90).
A factorial design (Genotype-x-Treatment) was used to identify regions showing a significant interaction, where task-related activity was modulated both by the genetic status and stimulant exposure. This was observed in only one region of the orbitofrontal cortex (OFC) (P = 0.018 corrected for cluster size) (Figure 1) . Subjects without the risk allele showed increased activation of this region following placebo, but reduced activation following amphetamine. However, the converse relationship was observed in those with the risk allele, with normal OFC activity only seen following amphetamine administration.
One prominent contemporary hypothesis suggests that reduced sensitivity to natural rewards may lead predisposed individuals to take stimulant drugs in an effort to gain this reward. 3 The DAT is one of the main targets for psychostimulant drugs and its inhibition leads to significant elevation of dopamine concentration 1 in mesolimbic, mesocortical and nigrostriatal circuits. OFC and striatal areas are connected enabling the signalling of values that guide our behaviour, allowing inhibitory control of the non-adaptative actions. 4 Through the effect on this mechanism, a functional polymorphism of DAT may influence both the reinforcing effects of a drug within the striatum, and have an upstream effect on the representation of the saliency of the drug through the OFC. Animal and human studies support these results: decreased DAT expression is related to hyperlocomotion and worse adaptation to new environment in mice, 5 whereas in humans, it is associated with chronic stimulant abuse and severity of positive psychotic symptoms. 6 Another indicator of dopamine system function, striatal dopamine D2 receptor levels, has also been shown to affect sensitivity to reward and orbitofrontal metabolism, with low D2 receptors associated with a blunted striatal and orbitofrontal reward response and a predisposition to abuse drugs showing more pleasurable effects and elevated OFC activity. 7, 8 These findings suggest that the altered orbitofrontal function may contribute to behavioural disinhibition, reflected in an increased compulsion to take stimulant drugs, a core feature of addiction. The increased OFC activity in cocaine abusers given methylphenidate, with decreases in non-addicts, 9 and the attentional bias in homozygous healthy subjects for the risk allele 10 support our results. To confirm these effects, we examined the effect of the Int8 VNTR 3 and 2 alleles on expression of a reporter gene and its response to amphetamine. As the location of the Int8 VNTR was within the gene, away from the 5 0 or 3 0 regions, we used a modified renilla vector with a unique intronic Asc1 site to allow us to examine potentially interesting intronic regulatory domains. The Int8 VNTR, when cloned in this domain and transfected into the dopaminergic SN4741 cell line, showed a reproducible and statistically significant increase at baseline (Student's t = 2.64, df = 27 and P < 0.05) in reporter gene expression supported by the 2 allele of the Int8 VNTR versus that supported by the 3 allele. We then tested the response of the Int8 VNTR 2 and Int8 VNTR 3 alleles to distinct challenges in the form of amphetamine, 
